What is the ROCE (Return on Capital Employed) of Veracyte this year?
The ROCE of Veracyte is -0.02 undefined this year.
Veracyte ROCE 2024
Veracyte ROCE
-0.02
Ticker
VCYT
ISIN
US92337F1075
WKN
A1W7EA
In 2024, Veracyte's return on capital employed (ROCE) was -0.02, a -52.47% increase from the -0.04 ROCE in the previous year.
Veracyte Aktienanalyse
What does Veracyte do?
Veracyte Inc is a company that specializes in the development and marketing of diagnostic tests for a wide range of diseases and disorders. The company was founded in 2008 and is headquartered in South San Francisco, California. The history of Veracyte Inc begins with the vision to help patients with better diagnostic options. The company has used its expertise in gene expression technology to develop tests that facilitate the diagnosis of diseases and disorders in various areas, such as cancer, thyroid diseases, and lung diseases. Veracyte Inc's business model is based on selling diagnostic tests to healthcare facilities, hospitals, doctors, and other medical institutions. The tests are performed by specially trained professionals and can provide a precise diagnosis that helps doctors plan individualized treatment. Veracyte Inc is divided into different divisions to offer the best and most precise test for each area. The divisions include cancer diagnosis, thyroid diagnostics, lung diagnostics, and other areas of gene expression technology. In cancer diagnosis, Veracyte Inc offers tests for various types of cancer, such as breast cancer, thyroid cancer, and lung cancer. The tests use RNA sequencing to analyze the patient's genetic information and provide a more precise diagnosis. In thyroid diagnostics, Veracyte Inc offers tests for various thyroid diseases that are often difficult to diagnose. The tests help avoid unnecessary surgeries or medical interventions and enable patients to receive a more accurate diagnosis and treatment. In lung diagnostics, Veracyte Inc offers tests for pneumonia, lung cancer, and other lung diseases. The tests use RNA sequencing and imaging to provide accurate diagnoses that help doctors recommend tailored treatment. In addition to these divisions, Veracyte Inc also offers other products and services, such as information campaigns and training for healthcare professionals, as well as support and counseling for patients and their families. Overall, Veracyte Inc aims to revolutionize the medical field and provide patients with better diagnosis and treatment options. The company's tests offer doctors and patients a more precise and personalized diagnosis, allowing for individualized treatment and achieving the best results. Veracyte ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Veracyte's Return on Capital Employed (ROCE)
Veracyte's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Veracyte's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Veracyte's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Veracyte’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Veracyte stock
How has the ROCE (Return on Capital Employed) of Veracyte developed compared to the previous year?
The ROCE of Veracyte has increased by -52.47% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Veracyte?
A high Return on Capital Employed (ROCE) indicates that Veracyte has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Veracyte?
A low ROCE (Return on Capital Employed) can indicate that Veracyte has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Veracyte impact the company?
An increase in the ROCE of Veracyte can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Veracyte affect the company?
A decrease in ROCE of Veracyte can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Veracyte?
Some factors that can affect Veracyte's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Veracyte so important for investors?
The ROCE of Veracyte is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Veracyte take to improve the ROCE?
To improve the ROCE, Veracyte can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Veracyte pay?
Over the past 12 months, Veracyte paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Veracyte is expected to pay a dividend of 0 USD.
What is the dividend yield of Veracyte?
The current dividend yield of Veracyte is .
When does Veracyte pay dividends?
Veracyte pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Veracyte?
Veracyte paid dividends every year for the past 0 years.
What is the dividend of Veracyte?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Veracyte located?
Veracyte is assigned to the 'Health' sector.
Wann musste ich die Aktien von Veracyte kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Veracyte from 9/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Veracyte pay the last dividend?
The last dividend was paid out on 9/6/2024.
What was the dividend of Veracyte in the year 2023?
In the year 2023, Veracyte distributed 0 USD as dividends.
In which currency does Veracyte pay out the dividend?
The dividends of Veracyte are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Veracyte stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Veracyte
Our stock analysis for Veracyte Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veracyte Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
